Back to Journals » Drug Design, Development and Therapy » Volume 11

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

Total article views   HTML views PDF downloads Totals
10,963 Dovepress* 10,363+ 1,307 11,670
PubMed Central* 600 186 786
Totals 10,963 1,493 12,456
*Since 24 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar